{
  "company": {
    "name": "Rarity Bioscience",
    "website": "https://raritybioscience.com/",
    "record": "https://startuphistory.org/c/raritybioscience.com"
  },
  "status": null,
  "history_since": null,
  "baseline": null,
  "live_captures": 0,
  "last_checked": null,
  "live_status": "offline",
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Foresight Diagnostics",
      "record": "https://startuphistory.org/c/foresight-dx.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both offer ultra-sensitive ctDNA liquid biopsy mutation detection assays for research and clinical applications."
    },
    {
      "name": "Enumera Molecular",
      "record": "https://startuphistory.org/c/enumeramolecular.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both provide platforms and assays for highly sensitive liquid biopsy and complex molecular diagnostics."
    },
    {
      "name": "AccuraGen, Inc.",
      "record": "https://startuphistory.org/c/accuragen.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both develop liquid-biopsy technologies to detect and monitor cancer using circulating tumor DNA."
    },
    {
      "name": "mDETECT",
      "record": "https://startuphistory.org/c/mdetect-inc.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both commercialize highly sensitive blood-based assays to monitor cancer via circulating tumor DNA signals."
    },
    {
      "name": "Delfi Diagnostics",
      "record": "https://startuphistory.org/c/delfidiagnostics.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both focus on blood-based DNA liquid biopsy for early cancer detection, though using different technical approaches."
    },
    {
      "name": "Adela",
      "record": "https://startuphistory.org/c/adelabio.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both support blood-based tests for cancer detection and MRD monitoring from circulating DNA."
    },
    {
      "name": "Nucleix",
      "record": "https://startuphistory.org/c/nucleix.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both work on non-invasive ctDNA liquid biopsies for cancer detection and monitoring."
    },
    {
      "name": "Mercy BioAnalytics",
      "record": "https://startuphistory.org/c/mercybio.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both are developing blood-based liquid biopsy tests for early-stage cancer detection."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Rarity Bioscience” company record, https://startuphistory.org/c/raritybioscience.com"
}